{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:08:56Z","timestamp":1788998936189,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Population aging leads to rising chronic disease burden and healthcare costs. The metropolitan area of Genoa (Liguria), the oldest in Italy, is particularly affected. Since 2017, ASL3 has implemented a comprehensive health promotion strategy including risk-factor reduction initiatives and multidisciplinary care pathways for multimorbid patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To evaluate the impact of the comprehensive health promotion program on the prevalence of heart failure (HF), chronic kidney disease (CKD), and chronic liver disease (CLD), and on healthcare resource use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the ASL3 data warehouse, we analyzed trends in HF, CKD, and CLD prevalence from 2011 to 2023 and compared yearly prevalence between 2011 and 2019 and 2020\u20132023. Hospitalization, outpatient activity and drug-prescription data were assessed; production and pharmaceutical costs were calculated. Regression models evaluated changes in prevalence trajectories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The resident population and average age increased slightly (from 704,355 to 711,133 people; from 49 to 51 years old). The unadjusted and standardized prevalence of HF, CKD and CLD rose significantly over the study period. However, after regression analysis, significance was confirmed only for the period 2011\u20132019. In 2020\u20132023, prevalence continued to rise, but at a substantially slower rate, suggesting an attenuation of the upward trend.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A multifaceted, system-wide prevention and care model may attenuate the upward trend in chronic-disease prevalence in highly aged populations. These findings support integrated health-promotion strategies as a sustainable approach to chronic disease management and resource stewardship.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40520-026-03429-w","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:26:05Z","timestamp":1782390365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Building healthier communities: effectiveness and cost-sustainability of the ASL3 GENESIS program for chronic diseases prevention"],"prefix":"10.1007","volume":"38","author":[{"given":"Luigi C.","family":"Bottaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Caltabellotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Cevasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Camellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Testino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bottino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Di Matteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Grego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Degli","family":"Esposti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"3429_CR1","unstructured":"Department of Economic and Social Affairs, Division P, United Nations (2024) World population prospects 2024. United Nations. https:\/\/population.un.org\/wpp\/?_gl=1*13zi8ip*_ga*NTk4NDQyODAwLjE3NjIwMTgxODk.*_ga_TK9BQL5X7Z*czE3NjIzNDU4OTEkbzIkZzEkdDE3NjIzNDU5MDgkajQzJGwwJGgw. Accessed 30 October 2025"},{"key":"3429_CR2","unstructured":"Istituto Nazionale di Statistica (2012) Indicatori demografici: stime per l\u2019ano 2011. ISTAT. https:\/\/www.istat.it\/comunicato-stampa\/indicatori-demografici-anno-2011\/. Accessed 30 October 2025"},{"key":"3429_CR3","unstructured":"Camera dei Deputati (2023) Rapporto Annuale ISTAT 2023: delineato il quadro demografico e i suoi effetti di lungo periodo sulla capacit\u00e0 di crescita dell\u2019Italia. Parlamento Italiano. https:\/\/temi.camera.it\/leg19\/post\/OCD15_14972\/rapporto-annuale-istat-2023-delineato-quadro-demografico-e-i-suoi-effetti-lungo-periodo-sulla-capacita-crescita-italia.html. Accessed 30 October 2025"},{"key":"3429_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/RMHP.S97248","volume":"9","author":"SM McPhail","year":"2016","unstructured":"McPhail SM (2016) Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag Healthc Policy 9:143\u2013156. https:\/\/doi.org\/10.2147\/RMHP.S97248","journal-title":"Risk Manag Healthc Policy"},{"key":"3429_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12916-022-02427-9","volume":"20","author":"PB Tran","year":"2022","unstructured":"Tran PB, Kazibwe J, Nikolaidis GF, Linnosmaa I, Rijken M, van Olmen J (2022) Costs of multimorbidity: a systematic review and meta-analyses. BMC Med 20:234. https:\/\/doi.org\/10.1186\/s12916-022-02427-9","journal-title":"BMC Med"},{"key":"3429_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1056\/NEJM196807252790405","volume":"279","author":"VR Fuchs","year":"1968","unstructured":"Fuchs VR (1968) The growing demand for medical care. N Engl J Med 279:190\u2013195. https:\/\/doi.org\/10.1056\/NEJM196807252790405","journal-title":"N Engl J Med"},{"key":"3429_CR7","unstructured":"New Brunswick Health Council (2016) The Cost of Chronic Health Conditions to New Brunswick. NBHC. https:\/\/nbhc.ca\/sites\/default\/files\/publications. Accessed 30 October 2025"},{"key":"3429_CR8","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.3399\/bjgp20X713897","volume":"71","author":"M Soley-Bori","year":"2020","unstructured":"Soley-Bori M, Ashworth M, Bisquera A, Dodhia H, Lynch R, Wang Y, Fox-Rushby J (2020) Impact of multimorbidity on healthcare costs and utilisation: a systematic review of the UK literature. Br J Gen Pract 71:e39\u2013e46. https:\/\/doi.org\/10.3399\/bjgp20X713897","journal-title":"Br J Gen Pract"},{"key":"3429_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/1355819613493772","volume":"18","author":"J Charlton","year":"2013","unstructured":"Charlton J, Rudisill C, Bhattarai N, Gulliford M (2013) Impact of deprivation on occurrence, outcomes and health care costs of people with multiple morbidity. J Health Serv Res Policy 18:215\u2013223. https:\/\/doi.org\/10.1177\/1355819613493772","journal-title":"J Health Serv Res Policy"},{"key":"3429_CR10","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1186\/s12913-025-13072-2","volume":"25","author":"T Horvath","year":"2025","unstructured":"Horvath T, Leoni T, Reschenhofer P, Spielauer M (2025) The impact of ageing, socio-economic differences and the evolution of morbidity on future health expenditure- a dynamic microsimulation. BMC Health Serv Res 25:952. https:\/\/doi.org\/10.1186\/s12913-025-13072-2","journal-title":"BMC Health Serv Res"},{"key":"3429_CR11","doi-asserted-by":"publisher","unstructured":"Torre E, Colombo GL, Di Matteo S, Martinotti C, Valentino MC, Rebora A, Cecoli F,Monti E, Galimberti M, Di Bartolo P, Gaggioli G, Bruno GM (2021) Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus. Clinicoecon Outcomes Res 13:503\u2013518. https:\/\/doi.org\/10.2147\/CEOR.S313577","DOI":"10.2147\/CEOR.S313577"},{"key":"3429_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40364-025-00728-8","volume":"13","author":"J Ran","year":"2021","unstructured":"Ran J, Zhou P, Wang J, Zhao X, Huang Y, Zhou Q, Zhai M, Zhang Y (2021) Global, regional, and national burden of heart failure and its underlying causes, 1990\u20132021: results from the global burden of disease study 2021. Biomark Res 13:16. https:\/\/doi.org\/10.1186\/s40364-025-00728-8","journal-title":"Biomark Res"},{"key":"3429_CR13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41581-022-00535-6","volume":"18","author":"AB der Beek","year":"2022","unstructured":"van der Aart-van, der Beek AB, de Boer RA, Heerspink HJL (2022) Kidney and heart failure outcomes associated with SGLT2 inhibitor use. Nat Rev Nephrol 18:294\u2013306. https:\/\/doi.org\/10.1038\/s41581-022-00535-6","journal-title":"Nat Rev Nephrol"},{"key":"3429_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","volume":"13","author":"SV Badve","year":"2025","unstructured":"Badve SV, Bilal A, Lee MMY, Sattar N, Gerstein HC, Ruff CT, McMurray JJV, Rossing P, Bakris G, Mahaffey KW, Mann JFE, Colhoun HM, Tuttle KR, Pratley RE, Perkovic V (2025) Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol 13:15\u201328. https:\/\/doi.org\/10.1016\/S2213-8587(24)00271-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3429_CR15","doi-asserted-by":"publisher","unstructured":"Kovesdy CP (2022) Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011) 12:7\u201311. https:\/\/doi.org\/10.1016\/j.kisu.2021.11.003","DOI":"10.1016\/j.kisu.2021.11.003"},{"key":"3429_CR16","doi-asserted-by":"publisher","first-page":"102614","DOI":"10.1016\/j.eclinm.2024.102614","volume":"72","author":"GM Chertow","year":"2024","unstructured":"Chertow GM, Correa-Rotter R, Eckardt KU, Kanda E, Karasik A, Li G, Christiansen CF, Stafylas P, Holt SG, Hagen EC, Garcia Sanchez JJ, Barone S, Cabrera C, Nolan S, Coker T, Webber L, Retat L (2024) Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study. EClinicalMedicine 72:102614. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102614","journal-title":"EClinicalMedicine"},{"key":"3429_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12325-022-02353-5","volume":"40","author":"N Tangri","year":"2023","unstructured":"Tangri N, Chadban S, Cabrera C, Retat L, S\u00e1nchez JJG (2023) Projecting the Epidemiological and Economic Impact of Chronic Kidney Disease Using Patient-Level Microsimulation Modelling: Rationale and Methods of Inside CKD. Adv Ther 40:265\u2013281. https:\/\/doi.org\/10.1007\/s12325-022-02353-5","journal-title":"Adv Ther"},{"key":"3429_CR18","doi-asserted-by":"publisher","first-page":"goae069","DOI":"10.1093\/gastro\/goae069","volume":"12","author":"R Manikat","year":"2024","unstructured":"Manikat R, Ahmed A, Kim D (2024) Current epidemiology of chronic liver disease. Gastroenterol Rep (Oxf) 12:goae069. https:\/\/doi.org\/10.1093\/gastro\/goae069","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"3429_CR19","doi-asserted-by":"publisher","unstructured":"Torre E, Di Matteo S, Bruno GM, Martinotti C, Valentino MC, Testino G, Rebora A, Bottaro LC, Colombo GL. Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives (2022) Clinicoecon Outcomes Res 14:607\u2013618. https:\/\/doi.org\/10.2147\/CEOR.S371778","DOI":"10.2147\/CEOR.S371778"},{"key":"3429_CR20","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1001\/jamainternmed.2024.4661","volume":"184","author":"F Kanwal","year":"2024","unstructured":"Kanwal F, Kramer JR, Li L, Yang YX, Cao Y, Yu X, Samuel R, Ali B, Desiderio R, Cholankeril G, Bajaj M, El-Serag HB, Asch SM (2024) GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Intern Med 184:1314\u20131323. https:\/\/doi.org\/10.1001\/jamainternmed.2024.4661","journal-title":"JAMA Intern Med"},{"key":"3429_CR21","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.injury.2018.04.014","volume":"49","author":"G Pioli","year":"2018","unstructured":"Pioli G, Bendini C, Pignedoli P, Giusti A, Marsh D (2018) Orthogeriatric co-management - managing frailty as well as fragility. Injury 49:1398\u20131402. https:\/\/doi.org\/10.1016\/j.injury.2018.04.014","journal-title":"Injury"},{"key":"3429_CR22","first-page":"281","volume":"47","author":"A Giusti","year":"2011","unstructured":"Giusti A, Barone A, Razzano M, Pizzonia M, Pioli G (2011) Optimal setting and care organization in the management of older adults with hip fracture. Eur J Phys Rehabil Med 47:281\u2013296","journal-title":"Eur J Phys Rehabil Med"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-026-03429-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-026-03429-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-026-03429-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:08:24Z","timestamp":1788995304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-026-03429-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3429"],"URL":"https:\/\/doi.org\/10.1007\/s40520-026-03429-w","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is a retrospective ecological observational study performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","label":"Human\/animal rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this retrospective ecological observational study formal consent is not required.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"186"}}